INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);UNIVERSITÉ PARIS DIDEROT - PARIS 7
发明人:
Nicolas CHARLES,Christophe PELLEFIGUES
申请号：
US15549401
公开号：
US20180021302A1
申请日:
2016.02.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.
